Manufacturing

Key challenges posed to autologous and allogeneic treatments could be resolved by in-vivo CAR-T gene therapies.

AbbVie and Capsida have expanded their existing collaboration to advance three new gene therapy programs.

GAO calls for more oversight of institutional review boards in clinical trials.

Agilent’s therapeutic nucleic acids facility gains architectural design support from CRB.

Webinar Date/Time: Thu, Mar 23, 2023 11:00 AM EDT

In this paper, the authors lay out some commonly accepted HCP analytical methods, the challenges of HCP assay, and provide recommendations on what can easily be accomplished in-house and when it may be better to outsource.

To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.

Webinar Date/Time: Wed, Mar 1, 2023 11:00 AM EST

The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.

Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling.

Webinar Date/Time: Tue, Feb 28, 2023 2:00 PM EST

Webinar Date/Time: Thu, Feb 23, 2023 11:00 AM EST

Webinar Date/Time: Tuesday, February 28th, 2023 at 11am EST | 8am PST | 4pm GMT | 5pm CET

The COVID-19 pandemic has led to many changes and shifts in the pharmaceutical industry, specifically with how pharmaceutical companies develop vaccines.

The change would impact every package and hundreds of systems.

CBM’s plasmid manufacturing offering is designed to provide phase-appropriate plasmids on demand for companies working on cell and gene therapies.

The new plasmid manufacturing facility aims to increase BioNTech’s autonomy and flexibility in manufacturing.

Improvements to Fluid Air’s Magnaflo filter blowback system are intended to increase powder yield in PolarDry Models 001 and 004.

Webinar Date/Time: Thursday February 24, 2023 at 11am EST | 10am CST | 8am PST

The COVID-19 pandemic has led to many changes and shifts in the pharmaceutical industry, specifically with how pharmaceutical companies develop vaccines.

Efforts to optimize the delivery of sensitive biotherapeutics continue to evolve.

ROSS’ Dual Shaft Mixers can batch dispersions, suspensions, and emulsions with viscosities up to several hundred thousand centipoise.

The BioProfile FAST CDV is a fully automated viable cell density and viability analyzer.

Bio-Rad Laboratories’ EconoFit Column Packs provide resin screening for customers developing protein purification workflows.

Thermo Fisher Scientific’s QualTrak is tailored for biologics development.